Pharma Journalist - Page 7 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Otsuka to Acquire Transcend in $1.2 Billion Deal

FDA Approves Lifyorli for Platinum-Resistant Ovarian Cancer

Tempus, Daiichi Sankyo Partner to Advance AI-Driven ADC Development

Cognito, Ochsner Launch Brain Health Collaboratory Initiative

Merck to Acquire Terns in $6.7 Billion Deal

UCB Wins EMA Support for Zilucoplan Pre-Filled Pen

Japan Approves Dupixent for Bullous Pemphigoid Treatment

Gilead to Acquire Ouro Medicines to Expand Autoimmune Portfolio

Merck, Quotient Partner to Discover New IBD Drug Targets

Viz.ai, Alnylam Partner to Improve Amyloidosis Diagnosis